Boosting cancer sensitivity to CDK4, CDK6 inhibitors by inhibiting the PRMT5-MDM4 axis

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; breast cancer; esophageal cancer; pancreatic cancer

Inhibiting the PRMT5-MDM4 axis could increase the sensitivity of melanoma and other cancers

Read the full 222 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE